Objective: To determinewhether treatment with interleukin-1 receptor antagonist (IL1-ra) would affect amnioticfluid concentrations of tumor necrosis factor alpha (TNF-α) and prostaglandins or clinical or microbiological outcomesin a model of ascending bacterial infection in pregnancy. Here, TNF is linked to bacterial infectious disease.